Profile data is unavailable for this security.
About the company
China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.
- Revenue in CNY (TTM)50.59bn
- Net income in CNY2.19bn
- Incorporated1999
- Employees3.14k
- LocationChina National Medicines Corp LtdNo. 12AYongwai Sanyuan West LaneDongcheng DistrictBEIJING 100077ChinaCHN
- Phone+86 1 067271828
- Fax+86 1 067271828
- Websitehttp://www.cncm.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Toho Holdings Co Ltd | 67.98bn | 823.36m | 13.99bn | 7.70k | 16.13 | 1.02 | 12.32 | 0.2057 | 242.08 | 242.08 | 20,008.50 | 3,831.19 | 1.81 | 14.05 | 4.05 | 188,375,100.00 | 2.20 | 1.83 | 6.09 | 4.35 | 7.94 | 8.60 | 1.21 | 0.9786 | 1.05 | -- | 0.1298 | 18.14 | 9.67 | 2.73 | 1.88 | -1.07 | -22.49 | 1.30 |
| China Medical System Holdings Ltd | 8.01bn | 2.40bn | 15.89bn | 5.70k | 6.62 | 1.02 | 6.08 | 1.98 | 1.06 | 1.06 | 3.53 | 6.84 | 0.4517 | 3.42 | 6.19 | 1,518,854.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| China Meheco Group Co Ltd | 40.47bn | 563.10m | 16.63bn | 8.31k | 29.54 | 1.49 | -- | 0.411 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
| Suzuken Co Ltd | 111.15bn | 1.30bn | 17.26bn | 13.43k | 14.06 | 0.9048 | 10.13 | 0.1553 | 336.97 | 336.97 | 28,802.96 | 5,236.47 | 1.82 | 12.94 | 4.05 | 176,574,900.00 | 2.12 | 1.77 | 6.33 | 4.64 | 7.75 | 8.05 | 1.17 | 0.9199 | 0.9883 | -- | 0.00 | 31.44 | 3.38 | 1.74 | 41.35 | 1.57 | 17.43 | 5.92 |
| Alfresa Holdings Corporation | 132.55bn | 1.49bn | 22.35bn | 11.77k | 14.41 | 0.9466 | 10.52 | 0.1686 | 163.14 | 163.14 | 14,454.60 | 2,483.23 | 1.92 | 15.08 | 4.12 | 240,225,700.00 | 2.17 | 2.47 | 6.17 | 6.52 | 7.24 | 7.34 | 1.13 | 1.24 | 1.03 | -- | 0.0607 | 33.25 | 4.27 | 0.7057 | -19.87 | -6.24 | 15.54 | 7.89 |
| Medipal Holdings Corp | 164.41bn | 1.75bn | 25.81bn | 12.80k | 14.15 | 0.9012 | 8.46 | 0.157 | 175.85 | 175.85 | 16,560.73 | 2,761.44 | 1.91 | 16.34 | 4.40 | 274,130,900.00 | 2.60 | 2.62 | 7.75 | 7.32 | 6.85 | 6.90 | 1.37 | 1.34 | 1.01 | -- | 0.00 | 27.22 | 2.10 | 1.32 | 31.89 | 2.21 | -15.04 | 6.23 |
| China National Medicines Corp Ltd | 50.59bn | 2.19bn | 26.22bn | 3.14k | 11.97 | 1.62 | -- | 0.5182 | 2.90 | 2.90 | 67.05 | 21.51 | 1.61 | 11.21 | 6.58 | 16,122,340.00 | 7.57 | 7.32 | 14.41 | 15.03 | 7.63 | 8.15 | 4.70 | 4.31 | 1.77 | -- | 0.1271 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| EBOS Group Ltd | 59.83bn | 1.21bn | 29.03bn | 5.20k | 23.69 | 2.58 | 15.20 | 0.4853 | 1.48 | 1.48 | 72.47 | 13.56 | 1.90 | 8.79 | 8.35 | 2,681,029.00 | 3.94 | 4.32 | 6.35 | 7.62 | 12.49 | 11.47 | 2.08 | 1.98 | 0.7358 | 6.79 | 0.4402 | 76.77 | 14.00 | 11.86 | 25.06 | 13.04 | 11.11 | 10.05 |
| China Resources Pharmaceutical Group Ltd | 244.75bn | 3.86bn | 29.50bn | 72.99k | 7.65 | 0.6418 | 2.70 | 0.1205 | 0.6629 | 0.6629 | 42.09 | 7.90 | 1.06 | 7.06 | 3.84 | 3,622,912.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| Jointown Pharmaceutical Group Co Ltd | 148.52bn | 2.17bn | 32.09bn | 30.10k | 15.01 | 1.31 | -- | 0.2161 | 0.5469 | 0.5469 | 37.57 | 6.28 | 1.53 | 8.05 | 3.96 | 4,934,201.00 | 2.31 | 3.01 | 7.85 | 9.72 | 7.68 | 8.24 | 1.50 | 1.98 | 0.9782 | 3.50 | 0.5673 | 34.73 | 6.92 | 11.50 | 4.88 | 14.16 | -10.39 | 39.14 |
Data as of Apr 18 2024. Currency figures normalised to China National Medicines Corp Ltd's reporting currency: Chinese Yuan Renminbi CNY
12.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 21.73m | 3.93% |
| Zhong Ou Asset Management Co., Ltdas of 20 Mar 2024 | 11.12m | 2.01% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 6.75m | 1.22% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 6.29m | 1.14% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 4.12m | 0.75% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 3.84m | 0.69% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 3.64m | 0.66% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2023 | 3.27m | 0.59% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.03m | 0.55% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 2.96m | 0.54% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
